102 related articles for article (PubMed ID: 38658617)
1. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma.
Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q
J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995
[TBL] [Abstract][Full Text] [Related]
2. Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing.
Xiong K; Fang Y; Qiu B; Chen C; Huang N; Liang F; Huang C; Lu T; Zheng L; Zhao J; Zhu B
Med Oncol; 2024 Mar; 41(5):93. PubMed ID: 38526643
[TBL] [Abstract][Full Text] [Related]
3. Comparative biology of human and canine osteosarcoma.
Mueller F; Fuchs B; Kaser-Hotz B
Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
[TBL] [Abstract][Full Text] [Related]
4. Comparative Immunology and Immunotherapy of Canine Osteosarcoma.
Mason NJ
Adv Exp Med Biol; 2020; 1258():199-221. PubMed ID: 32767244
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs.
Ammons DT; Hopkins LS; Cronise KE; Kurihara J; Regan DP; Dow S
Commun Biol; 2024 Apr; 7(1):496. PubMed ID: 38658617
[TBL] [Abstract][Full Text] [Related]
6. Single-cell RNA sequencing reveals the cellular and molecular heterogeneity of treatment-naïve primary osteosarcoma in dogs.
Ammons D; Hopkins L; Cronise K; Kurihara J; Regan D; Dow S
Res Sq; 2023 Aug; ():. PubMed ID: 37609233
[TBL] [Abstract][Full Text] [Related]
7. Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target.
Gingrich AA; Reiter TE; Judge SJ; York D; Yanagisawa M; Razmara A; Sturgill I; Basmaci UN; Brady RV; Stoffel K; Murphy WJ; Rebhun RB; Brown CT; Canter RJ
Front Immunol; 2021; 12():670309. PubMed ID: 34594320
[TBL] [Abstract][Full Text] [Related]
8. Single-Nuclei Multiome (ATAC + Gene Expression) Sequencing of a Primary Canine Osteosarcoma Elucidates Intra-Tumoral Heterogeneity and Characterizes the Tumor Microenvironment.
Nance RL; Wang X; Sandey M; Matz BM; Thomas A; Smith BF
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003552
[TBL] [Abstract][Full Text] [Related]
9. Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for COX-2 in tumour initiation.
Pang LY; Gatenby EL; Kamida A; Whitelaw BA; Hupp TR; Argyle DJ
PLoS One; 2014; 9(1):e83144. PubMed ID: 24416158
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling of canine osteosarcoma identifies prognostic gene expression signatures with translational value for humans.
Mannheimer JD; Tawa G; Gerhold D; Braisted J; Sayers CM; McEachron TA; Meltzer P; Mazcko C; Beck JA; LeBlanc AK
Commun Biol; 2023 Aug; 6(1):856. PubMed ID: 37591946
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral dendritic cell-CD4
Magen A; Hamon P; Fiaschi N; Soong BY; Park MD; Mattiuz R; Humblin E; Troncoso L; D'souza D; Dawson T; Kim J; Hamel S; Buckup M; Chang C; Tabachnikova A; Schwartz H; Malissen N; Lavin Y; Soares-Schanoski A; Giotti B; Hegde S; Ioannou G; Gonzalez-Kozlova E; Hennequin C; Le Berichel J; Zhao Z; Ward SC; Fiel I; Kou B; Dobosz M; Li L; Adler C; Ni M; Wei Y; Wang W; Atwal GS; Kundu K; Cygan KJ; Tsankov AM; Rahman A; Price C; Fernandez N; He J; Gupta NT; Kim-Schulze S; Gnjatic S; Kenigsberg E; Deering RP; Schwartz M; Marron TU; Thurston G; Kamphorst AO; Merad M
Nat Med; 2023 Jun; 29(6):1389-1399. PubMed ID: 37322116
[TBL] [Abstract][Full Text] [Related]
12. A single-cell RNA sequencing atlas of circulating leukocytes from healthy and osteosarcoma affected dogs.
Ammons DT; Harris RA; Hopkins LS; Kurihara J; Weishaar K; Dow S
Front Immunol; 2023; 14():1162700. PubMed ID: 37275879
[TBL] [Abstract][Full Text] [Related]
13. Strategies to overcome myeloid cell induced immune suppression in the tumor microenvironment.
Cao J; Chow L; Dow S
Front Oncol; 2023; 13():1116016. PubMed ID: 37114134
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review.
Thomas DD; Lacinski RA; Lindsey BA
J Bone Oncol; 2023 Apr; 39():100475. PubMed ID: 37034356
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
